Biotechnology/Chemical/Pharmaceutical Customer Partnership April 29, 2003
Tuesday, April 29, 2003
United States Patent and Trademark Office
Arlington, Virginia 22202
Patent Theater, Crystal Park 2, 2
nd
Floor
** Note New Location**
--SPECIAL MEETING FOCUSING ON APPLICATION OF THE UTILITY AND WRITTEN DESCRIPTION EXAMINATION GUIDELINES AND PRACTICES--
THIS PARTNERSHIP MEETING WILL FOCUS ON YOUR CONCERNS RELATING TO THESE CRITICAL AREAS OF PATENT PRACTICE. WE LOOK FORWARD TO HEARING YOUR CONCERNS AND ISSUES.
The most recent quarterly meeting for the Biotechnology and Chemical Pharmaceutical Customer Partnership was held on January 14, 2003, at the U.S. Patent and Trademark Office. The Biotechnology and Chemical Pharmaceutical Customer Partnership is designed and developed to be a forum to share ideas, experiences, and insights between individual users and the USPTO. The USPTO does not intend to use these customer partnership groups to arrive at any consensus. Invitations to participate will indicate that individual opinions are sought, rather than a group consensus and that the meetings are intended to be informal in nature and have varying participants. These customer partnership groups are formed with full recognition of the USPTO's responsibility under the Federal Advisory Committee Act (FACA), and that these customer partnership groups are not established as FACA compliant committees.
We value our customers in obtaining feedback from individual participants is important in our efforts to continuously improve the quality of our products and services. Your willing participation is helpful in providing us with insights and experiences in this informal process to assist us.
The next meeting of the US Patent and Trademark Office Biotechnology and Chemical Pharmaceutical Customer Partnership is scheduled for Tuesday , April 29, 2003 from 9:00 am to 4:30pm, Patent Theater, Crystal Park 2, 2 nd Floor, located on 2121 Crystal Drive, Arlington, Virginia.
Please contact Cecilia Tsang at 703-308-0254 or by fax at 703-746-7144 or email Cecilia.Tsang@uspto.gov or contact Sharlamar Taliaferro at 703-306-4094 or by fax 703-305-8002 or email Sharlamar.Taliaferro@uspto.gov to decline or confirm your attendance.
Biotechnology/Chemical/Pharmaceutical Customer Partnership
Tuesday, April 29, 2003
United States Patent and Trademark Office
Arlington, Virginia 22202
Patent Theater, Crystal Park 2, 2
nd
Floor
** Note New Location**
| Morning Session | ||
|
Time |
Subject
|
Speaker |
|---|---|---|
| 9:00-9:15AM | Greetings and Overview | Jasemine Chambers
John Doll Bruce Kisliuk Directors, TC 1600 |
| 9:15-9:30 AM | Opening Remarks | Jon Dudas, Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the USPTO. |
| 9:30-10:45 AM | Town Hall Meeting Part I "Utility" | Steve G. Kunin, Deputy Commissioner for
Patent Examination Policy.
Esther M. Kepplinger, Deputy Commissioner for Patent Operations. |
| 10:45-11:00 AM | Break | |
| 11:00-12:15 PM | Town Hall Meeting Part II "Written Description" | Steve G. Kunin, Deputy Commissioner for
Patent Examination Policy.
Esther M. Kepplinger, Deputy Commissioner for Patent Operations. |
| 12:15 PM -1:45 PM | Lunch Break | |
| Afternoon Session | ||
|
Time |
Subject
|
Speaker |
|---|---|---|
| 1:45 - 2:45 PM | ePhoenix and ePair | John Doll &
Mary Small |
| 2:45 - 3:00 PM | Break | |
| 3:00 - 4:00 PM | Priority Claims | Robert Spar , OPLA |
| 4:00 - 4:15 PM | Wrap Up | Jasemine Chambers
John Doll Bruce Kisliuk Directors, TC 1600 |
